Royalty Pharma plc (RPRX)
Royalty Pharma plc Gross margin
| Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 100.0% | 100.0% | 97.9% | 92.4% | 43.8% | 95.8% | 99.0% | 99.7% | 76.2% |
Royalty Pharma plc (RPRX) Gross margin comparison analysis
RPRX key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is Royalty Pharma plc's Gross margin?
As of today, Microsoft Corp's last 12-month Gross margin is 70.5%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Gross margin for Royalty Pharma plc have been 77.1% over the past three years, and 74.5% over the past five years.
2) Is Royalty Pharma plc's Gross margin Good?
As of today, Royalty Pharma plc's Gross margin is 70.5%, which is higher than industry median of 65.7%. It indicates that Royalty Pharma plc's Gross margin is Good.